- 孙敏. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. Cell Death & Disease, 15, 2024.
- 朱法良. Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host disease. Cellular and Molecular Immunology, 7, 133, 2024.
- . Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8 + T cell exhaustion and anti-PD-1 resistance. CELL REPORTS MEDICINE, 5, 2024.
- . Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity. Advanced Science, 2024.
- 武专昌. Peptide targeting the interaction of S protein cysteine-rich domain with Ezrin restricts pan-coronavirus infection. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 8, 2024.
- . Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. SCIENCE TRANSLATIONAL MEDICINE, 15, 2024.
- 张言坤. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. NATURE COMMUNICATIONS, 14, 2024.
- 秦丽萍. CRL4B complex-mediated H2AK119 monoubiquitination restrains Th1 and Th2 cell differentiation. Cell Death and Differentiation, 30, 1488-1502, 2024.
-
肝癌靶向长效CAR-T细胞的研发, 2023/12/08-2026/12/31
-
新型免疫检查点siglec-7/9小分子抑制剂的研发, 2024/08/01-2026/08/01
-
固有免疫稳态调控, 2023/08/24-2028/12/31
-
乙肝病毒感染临床转归 关键调控网络的精准绘制及干预新策略子课题-绘制乙肝治愈和再激活的关键分子调控网络及治疗新方案, 2022/12/01-2025/11/30
-
代谢-线粒体轴失调介导NK细胞衰老在肝癌免疫逃逸中的作用及机制研究, 2022/09/07-2027/12/31
-
免疫细胞技术开发及升级, 2022/04/01-2025/04/30
-
介导HBV肝脏免疫耐受/耗竭的关键卡控点的发现与验证, 2021/12/01-2024/11/30
-
肿瘤免疫逃逸关键抑制分子的鉴定及多靶向纳米抗体制备, 2020/12/16-2023/12/31